Showing results (51-60 of 386) with videos related to

Sort By:
Pageof 39
American Journal of Clinical and Experimental Urology|October 22, 2016
A metastatic castration resistant prostate cancer patient with multiple bone metastases has durable biochemical and radiological response to docetaxel chemotherapyTatsuaki Daimon, Takeo Kosaka, Mototsugu Oya
Frontiers in Oncology|October 4, 2014
Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Takeo Kosaka, Akira Miyajima, Mototsugu Oya
BMJ Case Reports|November 27, 2015
Continuous use of enzalutamide in a patient who developed enzalutamide-induced thrombocytopeniaAtsuko Sato, Takeo Kosaka, Mototsugu Oya
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 2, 2015
Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
BMJ Surgery, Interventions, & Health Technologies|January 24, 2025
Benefits, problems, and optimal timing of administration of indocyanine green fluorescence cholangiography in laparoscopic cholecystectomyShinichi Kinami, Kaori Maruyama, Yuta Sannomiya, et al.
Nihon Geka Gakkai Zasshi|April 30, 2005
[Lymphatic basin dissection and function-preserving limited gastrectomy for early-stage gastric carcinoma]Koichi Miwa, Shinichi Kinami, Hideyuki Ajisaka, et al.
Molecular and Clinical Oncology|December 15, 2018
Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxelTakeo Kosaka, Hiroshi Hongo, Ryuichi Mizuno, et al.
Reviews on Recent Clinical Trials|May 26, 2009
Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital CancerAkira Miyajima, Eiji Kikuchi, Takeo Kosaka, et al.
IJU Case Reports|August 4, 2020
Clinically complete response to abiraterone acetate in a patient with metastatic castration-resistant prostate cancerYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Scientific Reports|April 17, 2021
Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancerKeitaro Watanabe, Takeo Kosaka, Hiroshi Hongo, et al.
Pageof 39